Subscribe
Logo small
Search
Poland's drug safety

NIK begins ad hoc inspection. Under the inspectors' magnifying glass, among other things, AdA 2.0

MedExpress Team

Medexpress

Published Jan. 16, 2025 13:15

NIK begins ad hoc inspection. Under the inspectors' magnifying glass, among other things, AdA 2.0 - Header image
Fot . Robert Robaszewski / Agencja Gazeta
The Supreme Audit Office has decided to launch an ad hoc inspection to assess drug safety in Poland. The decision was made after an analysis of significant threats to the protection of citizens' health, including problems related to access to medicines and the functioning of the pharmaceutical sector.

Scope of control

The audit will cover key areas of the pharmaceutical system, including:

  • Reducing the number of pharmacies and limiting access to medicines for patients,
  • Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!